Publications by authors named "Richard Morter"

Claim this Profile
R
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.
Navin Venkatraman, Daniel Silman, Duncan Bellamy, Lisa Stockdale, Georgina Bowyer, Richard Morter

Lancet Microbe· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.
Navin Venkatraman, Alfred B Tiono, Georgina Bowyer, Duncan G Bellamy, Lisa K Stockdale, Richard Morter

Lancet Microbe· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Looped quality improvement project of consent forms in patients admitted with hip fracture.
Aniket Bharadwaj, Richard Morter, Ardeshir Bonshahi

J Clin Orthop Trauma· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso.
Richard Morter, Alfred B Tiono, Issa Nébié, Oliver Hague, Alphonse Ouedraogo

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Immune Phenotyping and Single-Cell Transcriptomics Allow Identification of Circulating TRM-Like Cells Which Correlate With Liver-Stage Immunity and Vaccine-Induced Protection From Malaria.
Andrés Noé, Mehreen S Datoo, Amy Flaxman, Mohammad Ali Husainy, Daniel Jenkin, Richard Morter

Front Immunol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Katie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, Hannah Sharpe, Rebecca Makinson, Richard Morter

Nat Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Katie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer, Hannah Sharpe, Rebecca Makinson, Richard Morter

Nat Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
Navin Venkatraman, Birahim Pierre Ndiaye, Georgina Bowyer, Djibril Wade, Saranya Sridhar, Richard Morter

J Infect Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials.
Georgina Bowyer, Tommy Rampling, Jonathan Powlson, Richard Morter, Daniel Wright

Vaccines (Basel)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining human paragonimiasis as a differential diagnosis to tuberculosis in The Gambia.
Richard Morter, Ifedayo Adetifa, Martin Antonio, Fatima Touray, Bouke C de Jong

BMC Res Notes· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting Malaria Hotspots: A Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction.
Polycarp Mogeni, Thomas N Williams, Irene Omedo, Domtila Kimani, Joyce M Ngoi, Richard Morter

J Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis